My ePortfolio Register   

AACR 2017 /
Final results of the HERACLES trial in HER2-amplified colorectal cancer

1st - 5th Apr 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.04.17
Views: 138

Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy

Dr Silvia Marsoni presents trial data at AACR 2017 from the HERACLES trial, in which patient-derived xenografts were able to guide treatment choices for cetuximab-resistant colorectal cancer.

To view the slides from this presentation, click here.

Dr Marsoni discussed these results further with ecancer here.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence